newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics to Host Virtual R&D Day for Investors on April 28, 2021

CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (TSX:TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it will host its virtual R&D Day for